AT A GLANCE
- Official wording
- Fat/volume loss is a post-market report
- Evidence limit
- Frequency and individual risk are not established
- Planning tool
- Real-time imaging supports layer identification
- Reviewed
- 23 September 2026
The short answer: it is a reported risk, not a predictable outcome
Ultherapy Prime's official US instructions list fat or volume loss among adverse events reported after market clearance. The same document explains that these reports come voluntarily from a population of uncertain size, so their frequency cannot be estimated reliably and a causal relationship cannot always be established. That means the risk should be discussed honestly, but the label does not show that facial fat loss is common or inevitable.
A 2025 systematic review found 19 peer-reviewed studies covering 506 people. Temporary swelling, redness and pain were the most common treatment-related effects in the published literature; the authors found one published case of subcutaneous atrophy. They also reviewed 106 FDA MAUDE reports, where lipoatrophy and neurologic complaints appeared, while stressing that these reports were largely anecdotal and unverified and cannot provide an incidence rate.
So the useful question is not whether every Ultherapy treatment removes facial fat. It is whether the planned tissue target, transducer, depth, area and line pattern fit your anatomy—and whether a clinician can explain where energy will and will not be placed before treatment begins.
What the device is designed to do—and why imaging matters
Ultherapy Prime combines focused-ultrasound therapy with real-time ultrasound imaging. The manufacturer says imaging is used to visualize dermal and subdermal tissue, check contact and confirm an appropriate treatment depth. The therapy creates discrete points of thermal coagulation rather than heating every layer evenly.
The US FDA recorded the Prime control unit under 510(k) K233996 in February 2024 as substantially equivalent to a legally marketed predicate. A 510(k) clearance is not a promise that a treatment is risk-free, and US indications do not automatically define Korean labeling or an individual treatment plan.
Le Moir Clinic currently offers Ultherapy Prime for face, jawline and neck lifting. Its official treatment page says consultation considers skin thickness, facial fat pads, the direction of laxity and prior filler or lifting treatments. That tissue-first assessment is especially relevant when a person is already lean or worried about hollowing.
- Ask the clinician to separate skin laxity from existing volume loss.
- Ask which areas are treatment targets and which areas will be avoided.
- Ask how real-time imaging changes the map for your tissue thickness.
- Bring records of previous filler, threads and energy-based treatments.
What current evidence can—and cannot—tell a lean face
The current evidence does not provide a reliable percentage for facial fat loss after Ultherapy Prime. Small clinical studies are not designed to detect every rare event, while voluntary post-market reports do not show how many treatments occurred or prove that the device caused every reported change. Both sources matter, but they answer different questions.
A 2018 five-patient case series described rare serious complications after microfocused ultrasound, including blistering, ulceration, tissue swelling, atrophy and necrosis. A case series can identify a possible harm signal; it cannot estimate the risk for the average patient or show that the same outcome follows current Prime treatment when used as instructed.
If a face is naturally thin, has recently lost weight or already looks hollow, the concern deserves a direct examination rather than a standard line package. Focused ultrasound is not a replacement for missing volume, and more lines are not automatically a better plan. Consultation only, a smaller area, a different target or postponing treatment can all be reasonable outcomes.

Who should pause for a more detailed consultation
A detailed physician consultation is particularly important when your main concern is hollowing rather than laxity, your facial shape changed quickly, you recently lost substantial weight, or you have an uncertain history of filler, threads or previous ultrasound and radiofrequency treatments. These details can change whether the proposed area and modality make sense.
The Ultherapy Prime instructions list open wounds or lesions, severe or cystic acne in the treatment area, and active or metallic implants in the treatment area among contraindications. They also identify precautions and areas to avoid. This guide cannot screen those conditions online, and it does not replace the product instructions or a medical history taken by the treating clinician.
It is also reasonable to stop if the consultation cannot name the exact device, treatment area, transducer, planned depth, line count, imaging step, expected reactions and follow-up route. A low price or a high line count does not answer an anatomy question.
Recovery, warning signs and a short Seoul itinerary
The official instructions describe temporary redness, swelling, discomfort, tenderness, bruising, welting and sensory or motor nerve effects among possible clinical-trial reactions. Burns and scarring are also described as possible when incorrect technique is used. Individual recovery varies, so 'no downtime' should not be treated as a fixed photo-ready date.
For an overseas visitor, leave practical time for the treating clinic to review increasing pain, blistering, unusual contour change, persistent weakness or numbness, vision change, a burn or another reaction that differs from the written aftercare. Sudden vision or neurologic symptoms require urgent medical assessment rather than an online message.
Share your arrival, event and departure dates before booking. Ask for the treatment record, device name, treated areas, line count and aftercare in English, plus a contact route that still works after you leave Korea. If your schedule cannot hold an examination before the flight home, postponing can be the more thoughtful choice.
A fair Ultherapy quote is also a treatment map
This safety guide does not compare overseas and Seoul prices because a cost comparison cannot hold anatomy, mapped area, transducer selection, line count, physician involvement, imaging, pain management, VAT and follow-up constant. It therefore makes no claim that Seoul is cheaper.
Ask for one written plan that identifies the genuine Ultherapy Prime system, exact areas, total lines, imaging before energy delivery, clinician, pain-management approach, VAT, aftercare and review. If a package advertises only 'full face' and a line count, ask what that wording means for the temples, cheeks, jawline, under-chin area and neck.
Friendly advice: bring an unfiltered photograph from before any recent weight or volume change. It will not diagnose the problem, but it can help you and the doctor discuss what you want to preserve—not only what you want to tighten.
PRICE CONTEXT · SEPTEMBER 2026
What a fair comparison includes
A safety-focused Ultherapy comparison is meaningful only when the same device, mapped areas, transducers, line count, imaging, physician involvement, VAT, pain management and follow-up are matched. We did not verify a like-for-like international pair for this question.
| Market | Price | Comparison basis |
|---|---|---|
| United States | No matched safety-plan price | Public prices did not hold the exact mapped areas, transducers, imaging, line count, tax and follow-up constant |
| Europe | No matched safety-plan price | Public prices varied by area, lines and clinical package, so no numeric comparison is made |
| Le Moir Clinic · Seoul | Current written quote required | Confirm mapped areas, transducers, lines, physician plan, imaging, VAT and follow-up after assessment |
No currency conversion is shown because no like-for-like public price pair was verified. If you later compare written quotes, use the European Central Bank's dated reference rates and keep the device, mapped area, transducer, line count, imaging, tax and follow-up basis constant ECB reference rates.
No Korea-versus-overseas savings claim is made. Compare the treatment map and follow-up plan—not a headline line count alone.
COMMON QUESTIONS
Before you book
Does Ultherapy always cause facial fat loss?
No. Fat or volume loss is listed in the official instructions as a post-market report, but the frequency cannot be estimated reliably and causation cannot always be established. The available literature does not show that it happens to everyone.
Is Ultherapy Prime suitable for a thin face?
Possibly, but a thin face needs an anatomy-led assessment rather than a standard package. The clinician should distinguish laxity from existing volume loss, review prior treatments and explain the areas, depths and line pattern being proposed—or recommend waiting.
Can real-time imaging prevent every complication?
No. Imaging helps the trained user visualize tissue, check contact and confirm treatment depth, but it does not make the procedure risk-free or replace anatomy, technique, product instructions and follow-up.
How can I reduce uncertainty before Ultherapy in Seoul?
Ask for the genuine device, mapped treatment and avoid areas, transducers, depth, total lines, imaging step, expected reactions, important warning signs, clinician, VAT and follow-up route. Share prior treatment records and your flight and event dates.
What should I do if my face looks unexpectedly different afterward?
Contact the treating clinic promptly for an in-person assessment, especially with increasing pain, blistering, a burn, weakness, numbness, vision change or progressive contour change. Sudden visual or neurologic symptoms require urgent medical care.
SOURCES & FURTHER READING
Check the original information
- Le Moir Clinic — official Ultherapy Prime treatment overview
- Merz Aesthetics — Ultherapy Prime US Instructions for Use
- US FDA — Ulthera System Prime 510(k) K233996
- PubMed — 2025 systematic review of MFU-V adverse events
- PubMed — case series of rare microfocused-ultrasound complications
Published September 23, 2026 · Last reviewed for factual accuracy September 23, 2026. Product availability, regulation and clinic pricing can change.


